131 related articles for article (PubMed ID: 38828630)
1. The Application of Goal Attainment Scaling in Cervical Dystonia - An Exploratory Observational Pilot Study.
Szabó M; Gárdián G; Szpisjak L; Salamon A; Gábor T; Klivényi P; Zádori D
Mov Disord Clin Pract; 2024 Jun; ():. PubMed ID: 38828630
[TBL] [Abstract][Full Text] [Related]
2. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
[TBL] [Abstract][Full Text] [Related]
3. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of cervical dystonia patients classified by the COL-CAP concept and treated with ultrasound-guided botulinum neurotoxin.
Szabó M; DO Kiem D; Gárdián G; Szpisjak L; Salamon A; Klivényi P; Zádori D
Ideggyogy Sz; 2023 Jan; 76(1-2):37-45. PubMed ID: 36892297
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
J Rehabil Med; 2021 Feb; 53(2):jrm00157. PubMed ID: 33616192
[TBL] [Abstract][Full Text] [Related]
6. Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD).
Odorfer TM; Malzahn U; Matthies C; Heuschmann PU; Volkmann J
Neurol Res Pract; 2019; 1():2. PubMed ID: 33324868
[TBL] [Abstract][Full Text] [Related]
7. Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.
Turner-Stokes L; Fheodoroff K; Jacinto J; Maisonobe P
BMJ Open; 2013 Jun; 3(6):. PubMed ID: 23794582
[TBL] [Abstract][Full Text] [Related]
8. Cervical dystonia: factors deteriorating patient satisfaction of long-term treatment with botulinum toxin.
Marciniec M; Szczepańska-Szerej A; Rejdak K
Neurol Res; 2020 Nov; 42(11):987-991. PubMed ID: 32693754
[TBL] [Abstract][Full Text] [Related]
9. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
Mullins D; Winter A; Fini N; Dixon C; Aldous S; Palit M; Holland AE
Disabil Rehabil; 2016 Sep; 38(19):1927-33. PubMed ID: 26714558
[TBL] [Abstract][Full Text] [Related]
10. The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia.
Hefter H; Samadzazeh S; Rosenthal D
J Neurol; 2021 Jan; 268(1):206-213. PubMed ID: 32761340
[TBL] [Abstract][Full Text] [Related]
11. Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A.
Marciniec M; Szczepańska-Szerej A; Papuć E; Rejdak K
Int J Neurosci; 2022 Oct; 132(10):1026-1030. PubMed ID: 33295845
[TBL] [Abstract][Full Text] [Related]
12. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
Turner-Stokes L; Ashford S; Jacinto J; Maisonobe P; Balcaitiene J; Fheodoroff K
BMJ Open; 2016 Jun; 6(6):e011157. PubMed ID: 27315835
[TBL] [Abstract][Full Text] [Related]
13. The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.
Oshima M; Deitiker P; Jankovic J; Atassi MZ
Immunol Invest; 2018 Jan; 47(1):18-39. PubMed ID: 28891721
[TBL] [Abstract][Full Text] [Related]
14. Goal Attainment: A Clinically Meaningful Measure of Success of Botulinum Toxin-A Treatment for Lower Limb Spasticity in Ambulatory Patients.
Choudhry S; Patritti BL; Woodman R; Hakendorf P; Huang L
Arch Rehabil Res Clin Transl; 2021 Jun; 3(2):100129. PubMed ID: 34124643
[TBL] [Abstract][Full Text] [Related]
15. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
[TBL] [Abstract][Full Text] [Related]
16. The effect of botulinum toxin on anxiety in cervical dystonia: A prospective, observational study.
Sugar D; Patel R; Comella C; González DA; Gray G; Stebbins GT; Mahajan A
Parkinsonism Relat Disord; 2023 Sep; 114():105792. PubMed ID: 37540934
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
López de Munain L; Valls-Solé J; Garcia Pascual I; Maisonobe P;
Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
[TBL] [Abstract][Full Text] [Related]
18. An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia.
Zhou X; Li ZF; Guo XZ; Wei Q; Niu YN; Li M; Xia JN; Chen LP
Technol Health Care; 2023 Nov; ():. PubMed ID: 38073352
[TBL] [Abstract][Full Text] [Related]
19. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
Yoshida K
Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420
[TBL] [Abstract][Full Text] [Related]
20. Therapy influences goal attainment following botulinum neurotoxin injection for focal spasticity in adults with neurological conditions.
Moore EJ; Olver J; Bryant AL; McKenzie DP; Williams G
Brain Inj; 2018; 32(7):948-956. PubMed ID: 29718712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
